Log in to save to my catalogue

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality an...

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0823d816c57e4beba790b8fb829a159d

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

About this item

Full title

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

Publisher

Beijing: Higher Education Press

Journal title

Protein & cell, 2018-01, Vol.9 (1), p.47-62

Language

English

Formats

Publication information

Publisher

Beijing: Higher Education Press

More information

Scope and Contents

Contents

Glycosylation of the Fc region of IgG has a profound impact on the safety and clinical efficacy of therapeutic antibodies. While the biantennary complex-type oligosaccharide attached to Asn297 of the Fc is essential for antibody effector functions, fucose and outer-arm sugars attached to the core heptasaccharide that generate structural heterogenei...

Alternative Titles

Full title

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0823d816c57e4beba790b8fb829a159d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0823d816c57e4beba790b8fb829a159d

Other Identifiers

ISSN

1674-800X

E-ISSN

1674-8018

DOI

10.1007/s13238-017-0433-3

How to access this item